Profile
Garth Lees-Rolfe currently works at Ludwig Enterprises, Inc., as Independent Director from 2025.
Mr. Lees-Rolfe also formerly worked at F-star Therapeutics, Inc., as Vice President-Finance from 2021 to 2022 and Inhibikase Therapeutics, Inc., as Chief Financial & Accounting Officer from 2024 to 2025.
Mr. Lees-Rolfe received his undergraduate degree from Queensland University of Technology.
Garth Lees-Rolfe active positions
| Companies | Position | Start |
|---|---|---|
| LUDWIG ENTERPRISES, INC. | Director/Board Member | 2025-06-22 |
Former positions of Garth Lees-Rolfe
| Companies | Position | End |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director of Finance/CFO | 2025-04-10 |
| F-STAR THERAPEUTICS, INC. | Corporate Officer/Principal | 2022-10-31 |
Training of Garth Lees-Rolfe
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Queensland University of Technology
Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig Enterprises, Inc.
Ludwig Enterprises, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
F-star Therapeutics, Inc.
F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
- Stock Market
- Insiders
- Garth Lees-Rolfe
















